Latest News and Press Releases
Want to stay updated on the latest news?
-
See attached file. Attachment 1. Reporting of transactions made by persons discharging managerial responsibilities ...
-
Ambu delivered 21% organic revenue growth in Q3, driven by an 81% increase in Visualization sales. COVID-19 significantly increased the demand for Ambu’s resuscitators and single-use scopes primarily...
-
Ambu is ready to launch single-use solution to help increase patient safety and prevent duodenoscope infections. Further devices for GI in development. The Ambu® aScope™ Duodeno received 510(k)...
-
Capital increase in connection with exercise of warrants Ambu A/S issued 2,000,000 warrants in 2014, 770,000 warrants in 2015, and 419,500 warrants in November 2016. Each warrant entitles the holder...
-
Accelerating commercial investments in GI and urology after submitting the aScope™ Duodeno for FDA-approval Ambu posted organic growth of 24% in Q2 as COVID-19 pandemic increased the demand for...
-
Accelerating commercial investments in GI and urology after submitting the aScope™ Duodeno for FDA-approval Ambu posted organic growth of 24% in Q2 as COVID-19 pandemic increased the demand for...
-
Ambu pre-announces results for Q2 2019/20 with organic revenue growth of 24% and sales of 313,000 single-use endoscopes. On this basis, the guidance for organic revenue growth for the full year is...
-
The Malaysian authorities have granted Ambu – as a manufacturer of medical devices – exemption from the two-week movement control order that has been declared with effect from 18 March, 2020. The...
-
With the rise in Covid-19 cases, the Malaysian government has declared that the entire country will be on a movement control order starting 18 March, 2020 and expected to end on 31 March, 2020. Ambu...
-
Ambu announces capital increase. Attachment Company_Announcement_no. 6 2019_20 ...